Medical Device News Magazine

Owen Mumford Acquires Empelvic

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Owen Mumford

Owen Mumford, a global leader in innovative medical device solutions, has announced the acquisition of pelvic floor cushion brand Empelvic, bolstering the company’s pelvic and sexual health portfolio with accessible solutions designed to help consumers treat conditions at their own pace.

Treatment of Pelvic Issues

With more people becoming hesitant at seeing a doctor for intimate health conditions it suggests that they are looking to treat pelvic and sexual health conditions at home, therefore the need for accessible and user-friendly products that support at-home treatment has never been more important[i]. With over 70 years of experience developing medical devices and pioneering several world-first technologies, Owen Mumford is expanding its offering to provide a comprehensive range of products covering multiple therapeutic areas but connected by a guiding mission to reimagine consumers’ approaches to intimate health.

Empelvic Was Established in Denmark

Previously a winner of the ‘Healthy Life’ category in the 2020 Danish Design Awards, Empelvic was established in Denmark by Midwife Gry Senderovitz and Entrepreneur Michael Severinsen and exists to provide an accessible and easy way to connect with your pelvic floor and improve your pelvic health. A non-invasive device, the shape is ergonomically designed to connect with the pelvic floor – with individual shapes for men and women. When sat on, the cushion helps to increase awareness of the pelvic floor and makes it easier to connect with the individual pelvic muscles, helping to engage them to train their strength gently and without harm. The device also helps people to relax their pelvic floor, in turn helping to treat a hypertonic pelvic floor. The distinctive product, designed to both relax and strengthen, is paired with user-friendly support that teaches how to easily establish, maintain, and strengthen a pelvic floor connection, regardless of age or gender. Empelvic has been created to help treat conditions like stress incontinence, vaginismus and erectile dysfunction by training the pelvic floor muscles[ii].

“The acquisition of Empelvic reinforces our commitment to comprehensive health solutions for intimate conditions,” said Adam Mumford, Director of Medical Devices at Owen Mumford. “By combining Owen Mumford’s global expertise with Empelvic’s innovative product, we aim to provide enhanced support and choices for individuals seeking pelvic health solutions.”

With Empelvic originating from Denmark, this acquisition also brings with it an exciting expansion into the wider Scandinavian territories. Co-founder Gry Senderovitz noted; “As a company with roots in Denmark, this strategic move allows us to leverage Owen Mumford’s extensive reach and resources, ultimately enhancing our ability to serve individuals seeking pelvic health solutions in Scandinavia and beyond. We look forward to the positive impact this acquisition will have on the lives of many as we continue our mission to make a meaningful difference in pelvic health and well-being.”

Empelvic will join Owen Mumford’s existing pelvic and sexual health portfolio alongside its Amielle Comfort and Care vaginal dilators and the Rapport vacuum therapy device, empowering individuals to take control of their pelvic and sexual well-being.

For more information on Empelvic please visit: https://claritistore.de/

[i] Kingsberg SA, Schaffir J, Faught BM, Pinkerton JV, Parish SJ, Iglesia CB, Gudeman J, Krop J, Simon JA. Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications. J Womens Health (Larchmt). 2019 Apr;28(4):432-443. doi: 10.1089/jwh.2018.7352. Epub 2019 Feb 4. PMID: 30714849; PMCID: PMC6482896.

[ii] Yaacov D, Nelinger G, Kalichman L. The Effect of Pelvic Floor Rehabilitation on Males with Sexual Dysfunction: A Narrative Review. Sex Med Rev. 2022 Jan;10(1):162-167. doi: 10.1016/j.sxmr.2021.02.001. Epub 2021 Apr 27. PMID: 33931383.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”